3-(2-carboxypiperazine-4-yl)propyl-1-phosphate has been researched along with pentobarbital in 1 studies
| Studies (3-(2-carboxypiperazine-4-yl)propyl-1-phosphate) | Trials (3-(2-carboxypiperazine-4-yl)propyl-1-phosphate) | Recent Studies (post-2010) (3-(2-carboxypiperazine-4-yl)propyl-1-phosphate) | Studies (pentobarbital) | Trials (pentobarbital) | Recent Studies (post-2010) (pentobarbital) |
|---|---|---|---|---|---|
| 15 | 0 | 0 | 10,272 | 175 | 439 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benardo, LS; Yang, L | 1 |
1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)propyl-1-phosphate and pentobarbital
| Article | Year |
|---|---|
Removal of superficial inhibition releases hyperexcitability in middle and deep horizontal slices from rat somatosensory neocortex.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Dantrolene; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Modulators; In Vitro Techniques; Muscle Relaxants, Central; Neocortex; Neural Inhibition; Pentobarbital; Piperazines; Pyramidal Cells; Rats; Seizures; Somatosensory Cortex; Synapses | 1998 |